Telomerase activity, Myc and Bcl-2: Possible indicators of effective therapy of prostate cancer with 9-nitrocamptothecin

Anticancer Research

Volumn 20, Issue 5, 2000, Pages 2885-2889

  Chatterjee, D ^a   Wyche, J H ^a   Romero, D P ^a   Pantazis, P ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

9 Nitrocamptothecin; Myc; Prostate cancer; Telomerase

Indexed keywords

MYC PROTEIN; PROTEIN BCL 2; RUBITECAN; TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TREATMENT OUTCOME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; HUMANS; MALE; MICE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033792766     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: Evidence for a specific receptor site and a relation to antitumor activity
2. Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitrocamptothecin
3. The water-insoluble camptothecin analogues: Promising drugs for the effective treatment of haematological malignancies
4. Preclinical studies of water-insoluble camptothecin congeners: Cytotoxicity, development of resistance, and combination treatments
5. Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins
6. Cellular senescence and cancer
7. Telomerase activation. One step on the road to cancer?
8. Telomere maintenance mechanisms and cellular immortalization
9. Role of telomerase in cellular proliferation and cancer
10. Inhibition of telomerase limits the growth of human cancer cells
11. Specific association of telomerase activity with immortal cells and cancer
12. A survey of telomerase activity in human cancer
13. Do telomerase antagonists represent a novel anti-cancer strategy?
14. Telomerase activity: A prevalent marker of human malignant prostate tissue
15. Telomeric DNA: Marker for prostate cancer development?
16. Myc activates telomerase
17. Direct activation of TERT transcription by c-MYC
18. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
19. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene
20. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
21. Bcl-2 modulates telomerase activity
22. Effects of differential overexpression of Bcl-2 on apoptosis, proliferation, and telomerase activity in Jurkat T cells
23. The male reproductive system: Prostatic cell lines
24. Induction of apoptosis in malignant and camptothecin-resistant human cells
25. Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues
26. Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins
27. Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumorigenic and tumorigenic cells in vitro
28. Regression of human breast tumors in immunodeficient mice treated with 9-nitrocamptothecin: Differential response of non-tumorigenic and tumorigenic human breast cells in vitro
29. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity
30. Bcl-2 family: Regulators of cell death
31. Telomeres and telomerase in normal and malignant haematopoietic cells
32. Anti-apoptotic role of telomerase in pheochromocytoma cells
33. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma
34. Telomerase activity, cell proliferation and cancer
35. The telomerase reverse transcriptase: Component and regulation
36. Telomere loss in cells treated with cisplatin
37. Telomerase enzyme activity and RNA expression in adriamycin-resistant human breast carcinoma MCF-7 cells
38. Human telomerase inhibition by 7-deaza-2'-deoxypurine nucleoside triphosphates
39. Telomerase activity in human solid tumors. Diagnostic utility and clinical applications
40. Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: In vitro studies with fresh human tumor samples
41. Survey of gene amplification during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays
42. Amplification and overexpression of p40 subunit of eukaryotic translation initiaton factor 3 in breast and prostate cancer
43. Antisense c-myc retroviral vector suppresses established human prostate cancer
44. Antiproliferative effects of c-myc antisense oligonucleotides in prostate cancer cells: A novel therapy in prostate cancer
45. Induction of DNA damage, inhibition of DNA synthesis, and suppression of c-myc expression by the topoisomerase I inhibitor, camptothecin, in MCF-7 human breast tumor cells